
Spanberger introduces legislation to require Congress members to electronically file disclosures
The “Easy to READ Act” would make it easier for the public to search, review and download the disclosures of elected officials.

The “Easy to READ Act” would make it easier for the public to search, review and download the disclosures of elected officials.
The bipartisan monthly meeting between Gov. Glenn Youngkin and Virginia’s congressional delegation this week got heated when Democrats Jennifer Wexton and Abigail Spanberger brought up Youngkin’s proposed anti-trans school policies, and Republican Bob Good defended the policies by claiming that schools and teachers are “grooming” children to change their gender.

The small business community has engaged Seventh District Congresswoman Abigail Spanberger to go to bat for them to get the SBA to flesh out its membership on its Small Business Regulatory Fairness Boards.

Following the Supreme Court’s decision to overturn Roe v. Wade, U.S. Rep. Abigail Spanberger announced July 20 her support for legislation to codify into law the right of Americans to access birth control.

U.S. Rep. Abigail Spanberger cosponsored the Arms Exports Delivery Solutions Act to reaffirm United States commitment to allies in Taiwan.

U.S. Rep. Abigail Spanberger (D-VA-07) will host a public telephone town hall on June 29 starting at 6:30 p.m. The town hall will focus on issues facing families, businesses, seniors, and the overall economy.

The recent spike in gas prices is in large part due to a lack of refining capacity. As oil demand has returned to pre-pandemic levels, global refining capacity has declined by 3 million barrels per day, and U.S. capacity alone has declined by 1 million barrels per day.

Abigail Spanberger yesterday co-led the introduction of bipartisan legislation to prevent future baby formula shortages and increase transparency within the formula industry.

Seventh District Congresswoman Abigail Spanberger today called on the Internal Revenue Service to expedite efforts to reduce its tax return backlog.

Pharmaceutical companies have regularly stopped producing key generic drugs. The reason: these medicines do not generate enough profit.
If you value our work, pitch in and help power Augusta Free Press in 2026 and beyond.